top of page

SUBSCRIBE TO OUR NEWSLETTER

THE LATEST NEWS IN CANCER CLINICAL RESEARCH

AT MEDSIR WE ARE DEDICATED TO OFFER THE MOST RELEVANT NEWS ON THE LATEST ADVANCEMENTS IN ONCOLOGY CLINICAL RESEARCH. FIND OUT THE LATEST NEWS ON ONCOLOGY RESEARCH, REGULATORY APPROVALS, EVENTS, SCIENTIFIC CONFERENCES AND MUCH MORE!

DOWNLOAD COMPANY DOSSIER

Search

DESTINY-BREAST03 results establish T-DXd as the standard of care for 2L metastatic breast cancer

Oct 12, 20213 min

CANCER RESEARCH

DESTINY-BREAST03 results establish T-DXd as the standard of care for 2L metastatic breast cancer

PARSIFAL: Identifying an endocrine agent for palbociclib in endocrine sensitive ABC

Oct 7, 20212 min

PARSIFAL: Identifying an endocrine agent for palbociclib in endocrine sensitive ABC

PATHFINDER Study (breast)

Oct 7, 20211 min

PATHFINDER Study (breast)

PARSIFAL Study (breast)

Oct 6, 20211 min

PARSIFAL Study (breast)

Pembrolizumab may be the new standard of care for RCC with intermediate to high risk of recurrence

Sep 30, 20214 min

CANCER RESEARCH

Pembrolizumab may be the new standard of care for RCC with intermediate to high risk of recurrence

Spotlight: PATHFINDER Breast cancer trial

Sep 24, 20213 min

CANCER RESEARCH

Spotlight: PATHFINDER Breast cancer trial

COPERNICO (Covid-19)

Sep 21, 20211 min

COPERNICO (Covid-19)

MEDSIR at ESMO 2021: Presentation of DEBBRAH and PATHFINDER study design

Sep 16, 20214 min

MEDSIR at ESMO 2021: Presentation of DEBBRAH and PATHFINDER study design

Ipilimumab-nivolumab combo as 2L does not improve survival for immunotherapy naive NSCLC

Sep 10, 20213 min

CANCER RESEARCH

Ipilimumab-nivolumab combo as 2L does not improve survival for immunotherapy naive NSCLC

COPERNICO Results at ERS: immunotherapy combo reduces hospitalization for COVID-19 pneumonia

Sep 2, 20213 min

COPERNICO Results at ERS: immunotherapy combo reduces hospitalization for COVID-19 pneumonia

El Global Interview: in a post-pandemic world, clinical research needs to be made even more flexible

Aug 27, 20211 min

El Global Interview: in a post-pandemic world, clinical research needs to be made even more flexible

COVID-19 Pandemic created a cancer screening deficit in the United States

Aug 23, 20212 min

CANCER RESEARCH

COVID-19 Pandemic created a cancer screening deficit in the United States

Apalutamide plus ADT improves overall survival in metastatic castration-sensitive prostate cancer

Aug 23, 20212 min

CANCER RESEARCH

Apalutamide plus ADT improves overall survival in metastatic castration-sensitive prostate cancer

ORPHEUS: A study of the efficacy of immunotherapy for advanced cases of penile cancer

Aug 19, 20216 min

ORPHEUS: A study of the efficacy of immunotherapy for advanced cases of penile cancer

New trial to evaluate abemaciclib and endocrine therapy vs. chemotherapy in advanced breast cancer

Aug 10, 20213 min

New trial to evaluate abemaciclib and endocrine therapy vs. chemotherapy in advanced breast cancer

ABIGAIL Study (breast)

Aug 10, 20213 min

ABIGAIL Study (breast)

Up to 30% of patients with metastatic breast cancer develop brain disease

Jul 16, 20213 min

CANCER RESEARCH

Up to 30% of patients with metastatic breast cancer develop brain disease

We explore new ways to treat breast cancer with brain metastases

Jul 2, 20212 min

We explore new ways to treat breast cancer with brain metastases

ZZFIRST Study (prostate)

Jul 1, 20211 min

ZZFIRST Study (prostate)

Announcing clinical trial with talazoparib for hormone-sensitive metastatic prostate cancer

Jun 29, 20212 min

Announcing clinical trial with talazoparib for hormone-sensitive metastatic prostate cancer

Adjuvant olaparib reduces recurrence and metastatic progression in patients with early breast cancer